Web Analytics Made Easy - StatCounter

Sirolimus Tenders

Get complete information related to latest Sirolimus Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Sirolimus Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Sirolimus Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Central Government/Public Sector

CTN :45335075 Due date: 05 Jun, 202605 Jun, 2026 NA
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of thestent to a major government institute. unit:no [ warranty period: 30 months after the date of delivery ] ]

Central Government / Public Sector

CTN :45339400 Due date: 08 Jun, 202608 Jun, 2026 NA
Tender For hq_med_sur_zrc_zonal rate contract for supply of ph:.(153045) sirolimus eluting stent cobalt - chromium stent with abluminal coating and specialised gradient coating (no polymer coating at joint & bends). bioresorbable polymer of plcl (poly lactic acid + poly caprolactone pcl) with degradation time of 3-4 months. low concentration of sirolimus (0.8ug/mm sq) should have bio-inspired open-cell. pmda approved ]

CTN :45292170 Due date: 01 Jun, 202601 Jun, 2026 3.77 Lacs
Tender For tender for supply of medicines and other medical consumables -lignocaine jelly 2% tube of 30gm , diclofenac inj , 75mg , paraceatmol syrup , 250mg/5ml. bottle of 60ml , febuxostate 40mg tab , adrenaline inj , pheniramine maleate/ avil inj , pheniramine maleate 25mg tablet , zolmitriptan nasal spray 7md , pramipexole 0.25mg tab , sodium valproate 333mg + valporic acid 145mg tab , diazepam 10mg , 2ml inj , chlorzoxazone (500mg) + diclofenac (50mg) + paracetamol (325mg) tab , albendazole 400mg tab , albendazole syrup 200mg/5ml , bottle of 10ml , itraconazole 100mg tab , methotrexate 5mg tab , ondansetron inj , 8mg , ondansetron 8mg tab , carbidopa 10mg+ levodopa 100mg tab , ropinirole 0.5mg tab , amantadine 100mg tab , trihexyphenidyl 2mg tab , methylcobalamine 1500mcg tab , tab topiramate 50mg , levetiracetam 500mg tba , ticagrelor 90mg tab , isosorbide dinitrate 10mg tab , enalapril 10mg tab , telmisartan 40mg tab , prazosin sr 5mg tab , enalapril 5mg tab , calamine lotion 100ml bottle , fexofenadine 180mg tab , glycerine liquid , 100gm bottle , mupirocin 2% ointment , 5gm tube , tab levosulpride 25mg , dicyclomine hcl 20mg + paracetamol 500mg tab , mebeverine hcl 135 mg tab , norflox & tinadazole tablet , ors sachet , thyroxine sodium 50mcg tab , sitagliptin 50mg + metformin 100mg tab , linagiptin 5mg tab , moxifloxacin eye/ ear drop , thyroxine sodium 100mcg tab , fexofenadine 120mg tab , fluticasone propionate 50mcg nasal spray , saline nasal drop , cinnarizine 25mg tab , xylometazoline (0.1% w/v) , fluvoxamine 50mg cap , lithium carbonate 500mg tab , tab ariprazole 15mg , olanzepine 10mg tab , trazadone 50mg tab , cough syrup diphenhydramine + ammonium chloride + sodium citrate , tamsulosin 0.4mg + dutasteride 0.5mg tab , vitamin b-complex tab , vitamin d3 sachet 60k u/1gm , rosuvastatin 20mg tab , azathioprine 75mg tab , betadine 10% solution , 100ml bottle , bupropion sr (sustained-release) 150mg tab , cap bio d3 strong , caroverine 40mg tab , dapagliflozin (10mg) + metformin (1000mg) + sitagliptin (100mg) , doxepin 75mg tab , duloxetine 20mg tab , foracort 400mcg 120mdi , forglyn inhaler , formoterol (4.8mcg) + glycopyrrolate (9mcg) mdi , glimepiride (3mg) + metformin (1000mg) , heptagon tab , hydrochlorothiazide 12.5mg tab , lodoz (bisoprolol (5mg) + hydrochlorothiazide (6.25mg) tab , lurasidone 40mg tab , methylcobalamin (750mcg) + pregabalin (75mg) , minoxidil 5% topical solution , nefrosave taurine (500mg) + acetylcysteine (150mg) tab , pancreatin 400mg capsule , silodosin 8mg + dutasteride 0.5mg tab , syp cetrizine 5mg/5ml , tab calcium with vitamin d3 , tab mesalazin 2pr 1.2gm , tab telma am 40/5mg , ursodeoxycholic acid 150mg tab , xylometazoline (0.5% w/v) , syrup cough , phenylephrine (5mg/5ml) + chlorpheniramine maleate (2mg/5ml) + dextromethorphan hydrobromide (10mg/5ml) , ambroxol (30mg) + guaifenesin (50mg) + salbutamol (1mg)

CTN :45146882 Due date: 25 May, 202625 May, 2026 1.00 Crore
Tender For empanelment for the supply of cathlab items on running contract basis under kasp and other schemes of this hospital - coronary stents, des,everolimus,fda/dcgi/ce approved platinum chromium platform,polyvinylidene fluride-hexafluropropyline pvdf-hfp polymer-stent lengths8,12,16,24,28,32. stent diameter 2.25*,2.50,2.75,3.00,3.50,4.00.struct thickness 81/86 microns.nominal pressure - 11 atm,rated burst pressure 16-18 atm, des,everolimus,fda/ approved platinum chromium platform,polyvinylidene fluoride-hexafluropropylene(pvdf-hfp)polymer, des,everolimus,fda/dcgi/ce/ approved platinum chromium platform,bioabsorbable polymer plga, everolimus eluting platinum chromium stent system, des, everolimus, l 605 cobalt chromium with hybrid cell design , strut thickness- 65microns, polymer- plga diameter- 2.25, 2.5, 2.75, 3.0, 3.5,4. length- 10,13,15,18,20,24, 28, 32,36,40, 42, 44, des, everolimus, cobalt chromium strut thickness - 63 microns . diameter- 2.25,2.5,2.75,3,3.5,4. length- 8,10,13,15,18,20,24,28,32,36,40,42,44. elutes 80% of drugs along with re plga polymer in the first 20 days, dcgi approved everolimus drug eluting 65 micron strut thickness with 3 micron plla&plga. a unique proprietory coating technology basedbiodegradable polymer stent with open cell designed and flexia finished technology based cobalt chromium l605 stent.a designed for optimal strength, flexibility ,trackablity ,side branch supported,bifurcation supported and high radial strength and optimal radiopacity and excellent vessel supported stent with revers alternative link design(ral) stent, with length from 8 mm to 52 mm and diameter from 2.25 mm to 4.50 mm, ce approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., ce approved sirolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., only dcgi approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 deg

CTN :45283436 Due date: 03 Jun, 202603 Jun, 2026 NA
Tender For supply of polymer free sirolimus eluting coronary stent, with microporous surface, abluminal coating, shellac resin and 10 years of safety and efficacy data. warranty: replacement warranty against any manufacturing defect noted on the o.t. table. [ai(2026-27), item code-no: s-62284, sl no.2183] ]

CTN :44698030 Due date: 25 May, 202625 May, 2026 NA
Tender For bid to ras corrigendum : supply of biodegradable polymer coated cobalt chromium sirolimus drug eluting stent system with ultrathin 60 m , biodegradable polymer co cr sirolimus drug eluting stent with 65 microns strut thickness assorted si

Central Government/Public Sector

CTN :45254443 Due date: 03 Jun, 202603 Jun, 2026 NA
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government / Public Sector

CTN :45267401 Due date: 02 Jun, 202602 Jun, 2026 NA
Tender For hq_med_sur_zrc_zonal rate contract for supply of ph:.(153047) biodegradable polymer sirolimus eluting coronary stent with stainless - steel platform having microporous surface, albuminal coating and shellac resin with diameters of 2.0 mm to 4.0 mm of varying length ]

CTN :45252717 Due date: 29 May, 202629 May, 2026 NA
Tender For supply of dglp drugs gem 03 niv disp 2026 27 g g - ltr packs , high potency calcium carbonate 1000mg magnesium hydroxide 240mgzinz 11mg and vit d3 500 iutab , waterless surgical hand antiseptic lotion chlorhexidine gluconate 1percentsolution and ethyl alcohol 61percentw w 1200ml , inj thiopentone 0dot5gm without water , quitiapine 25 mg tab , clomipramine 50mgtab , amisulpride 50 mg tab , amitriptyline 10 mg tab , aripiprazole 5 mg tab , mirtazepine 7dot5 mg tab , hydrogel colloid ointment 15 gm , inj ceftriaxone 1 g plus disodium adetate 37mg plus sulbactum 1 gm , inj ceftazidime 2 mg plus avabactum 0dot5 mg , niacinamidebutylene glycol enantia chlorantha bark extract oleanolic acid cream 50 gm , tab thalidomide 50 mg , tab thalidomide 100 mg , tab acyclovir 400 mg , corn cap , potassium permanganate crystals pack of 10gm , tolterodine 2mg la cap , mirabegrone 50 mg tab , nitrofurantoin macrosystaline sr 100mg tab , albumin powder 400gm , cholestyramine 4gm 5gm , inj ertapenem 1gm , inj anidulafungin 100mg , inj aztreonam 2gm , inj carbetocin 100 mcg ml , inj vit d 6 lac iu , inj doxycycline 100 mg , inj voriconazole 500 mg , inj clindamycin 600 mg , inj ceftriaxone 1000 mg plus disodium edetate 37 mg plus sulbactum 500 mg powder for infusion , tab empagliflozine 10mg plus linagliptin 5 mg , live freeze dried capsule lactic acid bacteria and bifidobacteria 112dot5 billlion cfu , cap amoxycillin plus tab clarithromycin plus tab esomeprazole 750mgplus500mgplus40mg , tab tenofovir alafenamide 25 mg , tab naltreoxone 25 mg , inj aqueous progesterone 50 mg , human menopausal gonadotropin 300iu inj , cream oestrdiol 1mg gm 15 gm with applicator , tab rifampicin 150mg plus isoniazid 75mg plus pyrazinamide 400mg plus ethambutol 275mg , tab rifampici 150mg plus isoniazid 75mg plus ethambutol 275mg , ketamine hydrochloride inj ip 50 mg ml 10 ml , 20percent intralipid 100 ml , tab citicoline 500 mg plus piracetam 800 mg , tab methylphenidate 5 mg , tab lemborexant 5 mg , tab thiamine 100 mg , tab varenicline 0dot5 mg , inj vitamin d3 600000 iu , tab tolvaptan 7dot5 mg , tab elobixibat 5 mg , tab acotiamide 100 mg , tab gavilson aluminium hydroxide 95 mg plus magnesium carbonate 358 mg , inj insulin lispro 200 iu ml in 3ml pfs , twinrab rabies monoclonal containing docaravimab 1500 iu 2dot5 ml with doseas erig 40iu kg , inj dantrolene sodium 20mg 10ml , inj phenylephrine 50mcg ml vial of 10 ml , inj zuclopenthixol 50 mg , inj zuclopenthixol 200 mg , tab tofisopam 50 mg , tab pregabalin 75 mg plusntp 10 mg , tab pimavanserin 34 mg , inj paliperidone 75 mg , tab methylphenidate sr 20 mg , tab atomoxetine 25 mg , tab nafithromycin 800mg , tab 12 sq hdm sublingual lyophilisate , inhalar budesinide glycopyrronium and formaterol fumarate dihydrate pressurized inhalation suspension 160 7dot2 5dot0mcg , tab bisoprolol fumarte 5 mg plusprindopril arginine 10 mg , tab trimetazidine extended release 80 mg , inj semaglutide 2mg 1dot5 ml , inj romiplostim 250 mg , tab vericignat2dot5mg , tab vericignat 5mg , tab vericignat 10mg , tab lemborexant 10mg , inj doxycycline 100mg vial , inj polymixin b 5lac unit vial , inj penicillin g , tab modafanil100mg , bacillus clausii spores oral suspension , lactobacillus paracasei gmnl 33 and cichorium intybus root oro dental tablet , ceftriaxone 2000mg sulbactum1000 mg and disodium edetate 74 mg , cefepime 2gm plus enmetazobactum 500 mg dry powder for injection , levonadifloxacin iv injection //bid details 2 / 91 800mg 100ml , multienzyme cleaning solution for instruments , tab tizanidine 2 mg , tab rimegepant 75 mg , sachet vigabatrin 500 mg , nerivio device , tab melatonin 3mg , tab melatonin 6mg , inj protamine sulphate 50 mg 5ml , omega 3 fatty acid , gla 120 gamma linolenic acid capsules , tab l carnitine 500 mg , magnesium coenzyme q10 , tab mirabegron er 50 mg , tab isoprirosine 500 mg , tab riluzole 50 mg , rotigotine transdermal patch 2mg 24h

CTN :44894091 Due date: 22 May, 202622 May, 2026 NA
Tender For bid to ras supply of usfda/dgci approved third generation sirolimus eluting des, cocr platform, biodegradable polymer hyb
 Loading, Please wait...

Connect us via What's Up